Navigation Links
BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)

NEWARK, N.J., March 15, 2011 /PRNewswire/ -- BioNeutral Group, Inc. (OTC Bulletin Board: BONU), a specialty life science technology-based company, today announced that it has entered into a global sales and distribution agreement with Raymond Associates LLC, a Service Connected Certified Disabled Veteran-Owned Business and executive management consulting firm. Under the terms of the agreement, Raymond Associates will represent BioNeutral's Military-Grade, patent-pending antimicrobial product Ygiene™ to the homeland security and government sectors in the Middle East, the United Kingdom and the United States.

Founded by the 20-year U.S. Army Certified Disabled American Veteran Kenneth R. Curley, Raymond Associates LLC has a proven track record of securing federal government contracts worldwide. "Working with Ken presents a unique opportunity to bring Ygiene™ MG throughout the regions of the world where the ever-present threat of a biological attack and warfare persist," said Stephen J. Browand President and CEO of BioNeutral Group, Inc. "As a result of our strategic partnership, we expect to secure new orders and government contracts for our Ygiene™ Military-Grade, which can quickly neutralize a wide variety of on-the-surface, biological contaminants and extremely dangerous microorganisms."

"We are extremely proud to be representing BioNeutrals' game-changing, Military-Grade Ygiene™ technology as a cutting edge defensive counter measure in both the U.S. and abroad," stated Kenneth R. Curley, President and CEO of Raymond Associates LLC. who went on to say, "Based on the independent testing results I have seen, Ygiene™ is a highly effective disinfecting/sterilizing power that is completely non-corrosive to ferrous metals, making it ideally suited for use on planes, ships and in today's hi-tech military vehicles. The Company's recently EPA-approved Hospital-Grade Ygiene™, will undoubtedly make a positive difference once put to use in our Military and VA hospitals and other healthcare facilities."

Founder and CEO of Raymond Associates, Kenneth R. Curley, is a West Point U.S. Military Academy graduate and distinguished Army officer veteran of over 20 years. Upon retirement in 1998, Mr. Curley was selected to serve within New York State government as the Director of Military Support, followed by Chief of Staff within the Division of Military and Naval Affairs. In 2003, Mr. Curley transitioned to the Country of Iraq, as the Deputy Director of Requirements Coordination in Baghdad and then as Chief of Staff Special Projects to the Coalition Provisional Authority.  In 2005, Raymond Associates supported the Emergency Response Efforts of Hurricane Katrina and Hurricane Rita.  Raymond Associates was founded in 2000, and has offices in New York, Florida, Baghdad, Iraq and the United Arab Emirates.

About Raymond Associates LLC Raymond Associates LLC is a Service Connected Disabled Veteran Owned Business that provides organizational development and executive management services in the United States, United Kingdom and the Middle East.  For more information, please visit

About BioNeutral Group, Inc.Headquartered at the New Jersey Institute of Technology/EDC in Newark, BioNeutral Group, Inc., is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace.  BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the Ygiene™ brand have been approved by the EPA for sale in the United States and has previously been approved for sale in Germany and it is also  permitted to be sold in the UK, France and Sweden. AutoNeutral is a Registered trademark of BioNeutral Group, Inc. For more information on BioNeutral, including a listing of company products, leadership and background please visit  

Find us on Facebook:

Follow us on Twitter:

Forward-Looking Statements

This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those described in the Company's filings with the Securities and Exchange Commission. BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA has approved and registered the Company's data and findings specific to Ygiene™ -206. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene™ and will soon be available for sale in the United States.Media Contact:Matt RizzettaNorth 6th Agencymrizzetta@north6thagency.com718-744-7138Investor Relations Contact:Jeff RamsonProActive Capital Resources Group, LLCjramson@proactivecrg.com212-792-4294  FOR THE COMPANY:Stephen J. BrowandBioNeutral Group, Inc.steve@bioneutralgroup.com973-286-2899

SOURCE BioNeutral Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioNeutral Group Secures Three Initial Trial Orders for its Ogiene™ Odor Neutralizer & Multi-Purpose Cleaner Product Line
2. BioNeutral Group to Receive Economic Development Incentives
3. Kentucky Hospital Association Solutions Group Outlines Next Steps for BioNeutral Partnership
4. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing
5. BioNeutral Groups CEO, Stephen Browand and Chief Scientist, Dr. Andrew Kielbania to Appear on WVOX 1460 AM In Focus Radio Show Hosted by Dr. Dan Miller
6. BioNeutrals Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.
7. BioNeutrals Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms
8. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase
9. BioNeutral Signs Agreement With a Non-profit for Long-Term Removal of Formaldehyde to Save 10,000 Mobile Homes in Louisiana
10. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
11. Pioneer® Surgical Technology, Inc. Enters the Biologics Extremities and Pelvis Market
Post Your Comments:
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology:
(Date:6/2/2016)... -- The Department of Transport Management (DOTM) of ... US Dollar project, for the , Supply and ... and IT Infrastructure , to Decatur ... of Identity Management Solutions. Numerous renowned international vendors participated in ... was selected for the most compliant and innovative solution. ...
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):